The High Cost of RSV Vaccines: Why Elderly sont Yet to be Mass Vaccinated
The article discusses why mass vaccination of the elderly against Respiratory Syncytial Virus (RSV) is not yet implemented, despite the availability of a vaccine. The main barrier is the high cost, with one dose priced at around 180-200 euros. This cost is a significant hindrance, as only one vaccination is needed, but the economic impact … Read more